BHCM
FLNA

Brevan Howard Capital Management’s Filana Therapeutics FLNA Stock Holding History

Brevan Howard Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,629
Closed -$193K – 1400
2024
Q2 		$193K Buy
+15,629
New +$329K ﹤0.01% 898

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brevan Howard Capital Management's FLNA Position: Q3 2024 in Review

Brevan Howard Capital Management sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 15,629 shares — an estimated $193K sold.

Brevan Howard Capital Management first reported a position in FLNA in Q2 2024 and held it in 1 quarter. The position peaked at $193K in Q2 2024. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Brevan Howard Capital Management reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 15,629 Filana Therapeutics shares in Q3 2024, an estimated $193K.
  • Brevan Howard Capital Management first reported a position in Filana Therapeutics in Q2 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Filana Therapeutics position peaked at $193K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.